Anti-body Coupled T Receptor Therapy is gaining momentum in the pharmaceutical industry for the treatment of various cancers
The next big hope in the fight against advanced cancers lies with Anti-body Coupled T Receptor Therapy . This technology combines genetic engineering with traditional therapy to create an efficient new cancer fighting agent. There are at least ten types of receptor therapies in the anti-cancer market, with an additional four developing over the next few years. Most of them involve using antibodies to target specific cancer cells, such as leukemia or melanoma. Others involve injecting antibodies directly into a tumor or a cancerous site to kill the root cause. One new class of drugs called systemic antigens is being developed for this purpose. These may provide the basis for a new anti-cellulite, anti-thrombotic, and anti-viral class of drugs in the future. For instance, in August 2021, Salipro Biotech partnered with the European Molecular Biology Laboratory, Germany to explore the efficacy of Salipro solutions in mAb (monoclonal antibody) discovery. The company has conducted stu...